The Lewisville, Texas-based orthopedic company designed the Rodeo Telescopic Nail to surgically treat deformities or fractures in osteogenesis imperfecta (OI) patients. The nail implant stabilizes the patient’s limb while also elongating (or telescoping) to accommodate the natural growth of pediatric patients.
“The launch of the Rodeo Telescopic Nail represents Orthofix’s continued commitment to address the underserved pediatric market with specialized solutions tailored to the specific needs and unique conditions, such as OI, of this patient population,” Orthofix President of Global Orthopedics Kim Elting said in a news release. “The Rodeo system has been very well received in Europe, and we are pleased to be able to announce this limited U.S. market release during National OI Awareness Week and join in educating others about this genetic bone disorder that is present at birth.”
Orthofix designed the nail implant to address many biomechanical and procedural challenges associated with current OI telescopic rod systems. Its design provides the strength and reliable bone fixation typically required when implanting in the fragile bones of OI patients.
According to the company, the implant procedure is streamlined. The system’s instrumentation and sterile pack configurations help optimize efficiency in the operating room and eliminate the need to sterilize trays.
The Rodeo Telescopic Nail will be available soon at some institutions in the U.S. Orthofix said the implant has been in clinical use in a limited number of European countries since 2022 with more than 170 surgeries performed.
